TrialClinical drug investigation2024

Efficacy and Safety of BP02 (Trastuzumab Biosimilar) in HER2-Positive Metastatic Breast Cancer: A Multicenter Phase III Study.

M V T Krishna Mohan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.